USFDA conducts inspection at Alkem's manufacturing facility located at St Louis, USA

20 Jun 2022 , 09:16 AM

Alkem Laboratories Ltd has informed to the exchanges that US FDA had conducted an inspection of the Company’s manufacturing facility located at St. Louis, USA from June 6-17, 2022.

As per the regulatory filing, at the end of the inspection, the Company has received Form 483 with three observations. The Company shall submit to US FDA within the stipulated timeline, a detailed response to close out all the observations associated with this inspection, said  Alkem.

On Monday early morning trade, Alkem Laboratories was trading at Rs3055.55 per share lower by 1.36% on the BSE.